-
Tolcapone, sold
under the
brand name Tasmar, is a
medication used to
treat Parkinson's
disease (PD). It is a selective,
potent and
reversible nitrocatechol-type...
-
opicapone (Ongentys)
tolcapone (Tasmar)
Entacapone and
opicapone are
peripheral inhibitors,
unable to
cross the blood-brain barrier.
Tolcapone is able to cross...
- and
tolcapone ... have been
demonstrated to
reduce the dose of L-DOPA
required and also
cause improvement in
clinical symptoms,
although tolcapone emerged...
-
tolcapone "orphan drug status" in
studies aiming at the
treatment of
transthyretin familial amyloidosis (ATTR). However, as of 2015[update]
tolcapone...
- of the
sympathetic nervous system.[citation needed] Some drugs, like
tolcapone (a
central COMT-inhibitor),
raise the
levels of all the catecholamines...
- the CNS
penetrant specific catecholamine-O-methyltransferase
inhibitor Tolcapone. Furthermore,
episodic memory is
enhanced through AZD3480, a selective...
-
Tiagabine Tianeptine Tiapride Thioproperazine Thioridazine Thiothixene Tolcapone Topiramate Tranylcypromine Trazodone Triclofos Trifluoperazine Trifluperidol...
- and end-of-dose
motor fluctuations – opicapone, entacapone, and
tolcapone.
Tolcapone has been
available for but its
usefulness is
limited by possible...
-
Catechol O-methyl
transferase (COMT)
inhibitors such as
entacapone and
tolcapone,
which are used in the
treatment of Parkinson's disease.
Dopamine β-hydroxylase...
-
treatment and prevention).
Tarceva (erlotinib), for
various cancers.
Tasmar (
tolcapone), for parkinson's disease,
licensed by
Mylan and
Bausch Health. Tecentriq...
